Tiotropiumbromid-Mikronisat

European patent · EP2298415 · In force

Register entry

Publication number
EP2298415
Application number
EP10180211
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Dec 7, 2006
Published
Mar 23, 2011
Granted
Jun 12, 2013
Protection ends at the latest
Dec 6, 2026
Next annual fee due
Dec 31, 2026
IPC classes
A61P 11/00 (2006.01)
A61K 31/40 (2006.01)
C07D 451/10 (2006.01)
Priority
DE 102005059602 14.12.2005
Divided from
EP06830454
Filing language
German
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 1, 2026

    Change

    Published in Swissreg on 01.01.2026

  2. Jan 1, 2025

    Change

    Published in Swissreg on 01.01.2025

  3. Jan 1, 2024

    Change

    Published in Swissreg on 01.01.2024

  4. Jan 1, 2023

    Change

    Published in Swissreg on 01.01.2023

  5. Jun 12, 2013

    Granted

    Published in Swissreg on 12.06.2013

Parties

Holder

Boehringer Ingelheim Pharma GmbH & Co. KG

Binger Strasse 173, 55216 Ingelheim, DE

Inventor

Rasenack, Norbert

55216, INGELHEIM AM RHEIN, DE

Walz, Michael

55216, INGELHEIM AM RHEIN, DE

Trunk, Michael Josef Friedrich

55216, INGELHEIM AM RHEIN, DE

Graebner, Hagen

55216, INGELHEIM AM RHEIN, DE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.